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Abstract
A major issue for public health policy is to reduce the poverty and catastrophic effects of out-of-pocket payments. This paper reviews empirical 
studies that analyze the financial burden of out-of-pocket payments and factors that are associated with this burden for households in the EU and ac-
cession countries. The method of systematic literature review is applied. Poverty effects appear to be independent of geographical area. Catastrophic 
healthcare expenditure ranges from a bit less than 0.05% to nearly 4%, and the impoverishment due to out-of-pocket payments is also up to 4%. 
Analyses carried out in single countries reveal that living in a household with a pensioner contributes most to high payments for health care. The 
results support calls for health policy to prevent the burden of out-of-pocket payments, especially for pharmaceutical expenditure. Special attention 
should be paid to risk groups such as pensioners, female headed households and low income households.
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Introduction
One of the fundamental goals of the public healthcare 
systems in Europe is to protect people from the negative 
financial consequences of illness by ensuring affordable 
and equitable health care [1]. At the same time, to ensure 
the financial sustainability of their healthcare system, 
many countries in Europe have introduced or increased 
patient charges over the past decade [2, 3]. The issue un-
derlying the increase of out-of-pocket payments (OPPs) 
is the shift of healthcare costs to the patients and their 
families. OPPs may pose a risk to the affordability and 
equity of the healthcare services [4]. Three forms of 
OPPs can be distinguished: (1) direct OPPs for services 
and goods, including consultation fees and the purchase 
of pharmaceuticals that are usually obtained in the pri-
vate sector and are outside the statutory benefit package; 
(2) user charges (cost sharing) applied to services and 
goods included in the statutory benefit package; (3) in-
formal payments or “under-the-table” payments, which 
can take the form of cash or in-kind gifts [5, 6]. OPPs are 
made at the point of service use and they are distinctive 
from health insurance premiums paid by the citizens.
The idea behind measuring the impact of OPPs on 
the household budget is that they are not regarded as 
equivalent to subsistence expenditures such as food 
and shelter [7]. Instead, OPPs do not always contribute 
to the overall wellbeing of a household and might have 
a negative impact on the household’s ability to pay. Two 
main approaches for measuring the financial burden of 
OPPs exist. When the household expenditure on health 
care exceeds a certain fraction of the household income 
or consumption, it is said that the household experiences 
‘catastrophic’ expenditure. When the household health-
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care spending pushes the households below a poverty 
line, it is said that the household experience ‘impoverish-
ing’ effects [8]. Both methods are extensively applied in 
the literature focused on developing countries [9–11].
At the European level, there are few studies that 
have focused on this issue. Until now, no review of the 
evidence on the financial burden of OPPs in Europe ex-
ists. Such review would however be important for add-
ing a European value to the affordability and equity of 
healthcare services, and for identifying the capacity of 
the European households to pay for health care. This 
paper addresses this gap in the literature. In particular, 
the paper aims to systematically review the recent em-
pirical evidence on the financial burden (poverty and 
catastrophic effects) of OPPs in the EU and accession 
countries and thus, to establish a base for future compara-
tive studies. This is a first effort to present a systematic 
compilation of publications related to this topic.
Background 
OPPs are one of the key sources of healthcare financ-
ing throughout the EU and accession countries [12]. Al-
though in the period 2000–2010, the share of OPPs in 
the total health expenditure has only slightly increased 
(+0.3%) on average in EU, there are notable changes be-
tween countries. For instance, a large decrease in OPPs 
is found in Poland (–7.9%), Italy (–6.7%) and Lithuania 
(–4.7%) whereas large increases are found in Slovakia 
(+15.3%), Bulgaria (+6.4%) and Cyprus (+5.9%) [2]. 
Overall, the share of OPPs in the total health expenditure 
varies considerably across countries. In 2010, this share 
was highest in Cyprus (49%), Bulgaria (43%) and Greece 
(38%), and it was lowest in the Netherlands (6%), France 
(7%) and the UK (9%) [2]. Less wealthy countries rely 
more on OPPs than wealthier countries.
In order to analyze the financial burden that OPPs 
create for households, it is necessary to define welfare 
measures. The literature on OPPs defines three general 
indicators of household welfare: income, consumption 
and expenditure. Consumption and expenditure are often 
used interchangeably because their levels are virtually 
similar [8]. They both capture household welfare in terms 
of the household’s ability to meet its basic needs. Income 
however can substantially differ from consumption and 
expenditure. Household financing mechanisms like sav-
ings, selling assets, taking credit or receiving transfers 
from family and friends can lead to a higher consumption 
level than their income would allow [13]. Also, consump-
tion accounts for long-term assets, which are not captured 
by the income indicator [8, 11]. In countries where infor-
malities prevail, the use of income as a welfare indica-
tor is also questioned since a large part of income might 
remain unreported or might be in a non-monetary form 
(e.g. agricultural products) [8, 13]. Nevertheless, the use 
of income is preferred when distinguishing between in-
come sources. It is also a useful indicator when the ability 
to pay should be taken into account because household fi-
nancing strategies such as selling assets and taking credit, 
which indicate inability to pay, are not included [8]. 
In addition to the welfare indicator chosen, it is also 
necessary to define the approach for measuring the finan-
cial burden of OPPs. As mentioned earlier, there are two 
main approaches: catastrophic expenditure and impov-
erishing effects. Based on the catastrophic expenditure 
approach, the fraction of the household income spent on 
health care or the fraction of consumption related to health 
care is compared to a predefined threshold. The threshold 
applied ranges from more than 5% to more than 40% de-
pending on the study setting and objectives [8, 11]. If this 
threshold is exceeded, catastrophic healthcare spending 
is registered. According to the impoverishing effects ap-
proach, household income or consumption after subtract-
ing the healthcare spending, is compared to a predefined 
poverty line. When the household falls below this poverty 
line, an impoverishing effect of OPPs is registered. The 
literature defines relative and absolute poverty lines. A rel-
ative poverty line is set at a certain percentage of the mean 
income or consumption, and therefore depends on the 
overall income or consumption in a country. The absolute 
poverty lines are generally defined based on estimates of 
the costs of basic food needs. Establishing poverty lines 
should be in accordance with social norms or the common 
understanding of what represents the minimum. Overall, 
the definition of thresholds in both approaches is some-
what arbitrary. Most importantly, changes in the threshold 
lead to very different estimates [8].
Research methods
This study has the form of a systematic literature 
review of empirical studies on the financial burden of 
OPPs in the EU and associated countries. The review 
is carried out in April-June 2013. The primary purpose 
is to appraise, select, identify and synthesize existing 
evidence on this topic. To identify relevant publications, 
the following combination of keywords (search terms) is 
used: EUROPEAN UNION and PATIENT PAYMENT 
and POVERTY. Moreover synonyms of the keywords are 
added and differences in spelling are considered. The fol-
lowing overall chain of keywords is used in the search: 
[EUROPEAN UNION or EU or EUROPE or AUSTRIA 
or BELGIUM or BULGARIA or CYPRUS or Czech 
REPUBLIC or DENMARK or ENGLAND or ESTONIA 
or FINLAND or FRANCE or GERMANY or GREECE 
or HUNGARY or IRELAND or ITALY or LATVIA or 
LITHUANIA or LUXEMBOURG or MALTA or THE 
NETHERLANDS or POLAND or PORTUGAL or ROMA-
NIA or SLOVAKIA or SLOVENIA or SPAIN or SWEDEN 
or UNITED KINGDOM] and [PATIENT PAYMENT or 
CO-PAYMENT or COPAYMENT or CO-INSURANCE 
or COINSURANCE or COST SHARING or DEDUCT-
IBLE or INFORMAL PAYMENT or OUT-OF-POCKET 
PAYMENT or USER FEE or USER CHARGE] and 
[POVERTY or EXGUITY or IMPOVERISHMENT or 
MEAGERNESS or PAUPERISATION or POORNES or 
CATASTROPHIC or IMPOVERISHING]
The following databases are searched: Embase, 
Pubmed and Web of Science. Inclusion criteria are related 
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to the nature and language of publications: only empirical 
studies published in English language are reviewed. The 
date of publication is limited to papers published since 
2000. To avoid information bias, only peer-reviewed 
papers are used. In addition, relevance criteria that con-
cern the content of the publications are established. We 
only include empirical studies that analyze poverty and 
catastrophic effects caused by OPPs for pharmaceuticals, 
medical devices, dental, mental preventative, long-term 
care, emergency care as well as inpatient and outpatient 
care. Studies published before 2000, as well as non-Eng-
lish and non-peer-reviewed studies are excluded from 
the review. We also exclude studies that analyze OPPs in 
general, as well as studies that discuss or describe pov-
erty and catastrophic effects caused by increased OPPs 
without providing empirical data. Studies that analyze 
increases in payments for health insurance to reimburse 
service provision are also excluded. 
The methodological and epistemological quality of 
research in this field is expected to be heterogeneous due 
to the different theoretical approaches that exist in quan-
tifying OPPs and poverty in general. Three main aspects: 
data collection, data analysis and research design are ana-
lyzed in order to exclude studies where an inappropriate 
or poor methodology is used. As study designs consider-
ably differ from each other, it is not feasible to carry out 
a quantitative analysis using the study results. Based on 
the data categorization, the results of the review are sum-
marized in the form of tables.
Results
The systematic literature review identified 121 pub-
lications. After reviewing titles and abstracts, eleven rel-
evant publications are selected for the analysis [14–24]. 
A summary of the publications can be found in the ap-
pendix. 
The scope of the studies ranges from looking at 
a single country or sub-region to a multi-country analy-
sis. Some studies measure the financial burden of OPPs 
caused by policy reforms. In the Czech Republic [18], 
relatively minor increases in the financial burden of 
OPPs have been registered after the implementation of 
user fees for publicly funded healthcare services. Another 
study reports poverty effects after reforms of the primary 
healthcare system in the western Balkan [15]. In Turkey, 
poverty effects are registered after the introduction of 
universal coverage in 2008 as part of the Health Transfor-
mation Program [24]. In Estonia, a drastic increase of the 
burden of OPPs during the transition period is reported 
[17, 20]. Some studies [14, 16, 19, 22] attempt to deter-
mine the strength of the financial burden or barriers to 
access. While in Latvia [22] the main interest is on the 
effect of the poorly defined public insurance schemes and 
the high share of OPPs in the total health expenditure, in 
Poland [19], the main interest is to analyze the poverty ef-
fects caused by the pharmaceuticals. Two studies [21, 23] 
apply catastrophic expenditure measurements to compare 
health system characteristics. Both studies include data 
on catastrophic expenditure from 21 European countries. 
The majority of the data come from household budget 
surveys. In some studies, specifically designed question-
naires are used [14, 15, 19]. All studies use expenditure 
or consumption as indicators. Some studies measure 
OPPs per household member [14–16, 18, 19, 24] while 
other studies use a mix of household members [17] or 
household level data [20]. Several measuring methods 
are used in the studies either alone or in a combination. 
The individual and household characteristics most 
often associated with financial burden of OPPs include: 
being a pensioner, being in the lowest income group, liv-
ing in a female headed households and households with 
more than one child. Other reasons for experiencing 
a high burden of OPPs are a low education level and be-
ing unemployed or out of the labor force. 
Table I compares all studies on catastrophic health-
care expenditures that are identified in the review. The 
table presents the year of the study, survey type, sample 
sizes, approximated average OPPs per household per 
year, catastrophic expenditure threshold, as well as the 
share of the sample that exceeds the catastrophic expend-
iture threshold. As indicated in the table, the sample size 
ranges from about 1000 to more than 25000 individu-
als. The highest OPPs per household per year are found 
in the Czech Republic (€ 280.80 in 2009) and the lowest 
in the Scandinavian countries and Turkey. However, the 
Czech Republic has very low rates of catastrophic OPPs. 
Thresholds for measuring catastrophic expenditure 
vary from 5% to up to 40%. Studies looking at a single 
country sometimes use lower thresholds to better capture 
the country effects. A lower threshold is also applied 
when the catastrophic effects of a specific OPPs compo-
nent is studied (e.g. OPPs for pharmaceuticals in Poland). 
At the 40% threshold, the catastrophic expenditure ranges 
from a bit less than 0.05% (e.g. in Czech Republic, Lux-
embourg and Slovakia) to up to 3.7% in Latvia in 2005.
It should be noted that the results presented in Table 1 
are difficult to compare due to differences in the year and 
design of the studies. Therefore, we look more closely 
at four studies that provide overall comparable results 
[16, 17, 22, 24]. These studies analyze the catastrophic 
expenditure in population quintiles by measuring the ef-
fects especially for the poorest quintile. The studies also 
make a distinction between different healthcare compo-
nents. As indicated by these studies, Estonia (threshold 
20%) and Latvia (threshold 40%) show a high disparity 
between the rich and poor quintiles in favor for rich quin-
tiles, while France and Turkey show equal proportions 
of catastrophic expenditures across quintiles. Also, Es-
tonia, Latvia and Turkey show a decrease in catastrophic 
healthcare expenditures across quintiles (from poor to 
rich) in case of pharmaceutical products and outpatient 
services. France shows an equal distribution across quin-
tiles in all healthcare components. It is important to men-
tion that Estonia and Latvia show a progressive distribu-
tion of catastrophic payments over income quintiles. 
The majority of papers also look at the impoverish-
ing effects of OPPs, i.e. the share of households that fall 
below a given poverty line after subtracting the OPPs 
[15–17, 19, 22, 24]. Moreover, three studies [15, 17, 19] 
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Country Reference Year of the study Data source Sample size
Average OPPs 
per household 
per year 
(in EUR)
Threshold
Share of 
the sample 
above the 
threshold [%]
Austria [21, 23] 1999/2000 Household 
Budget Survey
7086 not available 40% 0.2
Belgium [21, 23] 1997/1998 Household 
Budget Survey
2212 not available 40% 0.1
Bulgaria [21, 23] 1995
1997
2000
Integrated 
Household 
Survey
5701
2462
2618
not available 40% 0.9
2.4
2.2
Czech Re-
public
[21, 23] 1999 Household 
Budget Survey
2675 not available 40% 0.0*
Czech Re-
public
[6] 2007
2008
2009
Household 
Budget Survey
3000
3000
3000
213.60
277.20
280.80
20% 0.0*
0.2
0.1
Denmark [21, 23] 1997 Household 
Budget Survey
2675 40% 0.1
Estonia [4] 1995
2001
2002
Household 
Budget Survey
2816
5854
5499
44.44
106.8
116.4
40% 0.3
1.5
1.6
Estonia [4] 1995
2001
2002
Household 
Budget Survey
2816
5854
5499
44.44
106.8
116.4
20% 3.1
5.0
0.3
Estonia [7] 2000
2001
2002
2003
2004
2005
2006
2007
Household 
Budget Survey
44.44
44.44
49.92
61.44
72.96
74.49
114.43
120.58
20% 2.4
2.6
3.3
4.0
5.2
4.3
6.8
6.2
Finland [21, 23] 1998 Consumption 
Expenditure 
Survey
4348 40% 0.4
France [3] 1995
2001
2006
Family Budget 
Survey
9634
10305
10240
41.60
28.70
19.20
20% 4.0
3.0
2.0
France [3] 1995
2001
2006
Family Budget 
Survey
9634
10305
10240
41.60
28.70
19.20
40% 2.0
1.5
0.6
Germany [21, 23] 1993 Income and 
Consumption 
Survey
8094 not available 40% 0.0*
Greece [21, 23] 1998 Household 
Expenditure 
Survey
10191 not available 40% 2.2
Hungary [21, 23] 1993 Household 
Budget Survey
8094 57.60 40% 0.2
Iceland [21, 23] 1995 Household 
Budget Survey
1352 not available 40% 0.4
Latvia [21, 23] 1997/1998 Household 
Budget Survey
7648 not available 40% 2.8
Lithuania [21, 23] 1999 National Hou-
sehold Budget 
Survey
not available 40% 1.3
Luxembourg [21, 23] 1998 Enquête budget 
des ménages
8205 not available 40% 0.0*
Montenegro [2] 2004 (ISSP) House-
hold Survey
8205 not available 25% 0.4
Poland [21, 23] 1993 Household 
Budget Survey
16051 not available 40% 1.6
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analyze the severity of poverty looking at those house-
holds below the poverty line that become even more 
poor because of healthcare payments. The percentage of 
households dropping below the poverty line ranges from 
0.2% in France in 2006 up to 4.2% in Poland in 2009. 
Bearing in mind that the Polish study solely measures 
impoverishment caused by OPPs for pharmaceutical, this 
is a rather large effect. 
Discussion
As shown by the results of our review, the financial 
burden of OPPs is felt in most EU and accession coun-
tries but that countries differ in the extent of the burden. 
The percentage of households incurring catastrophic pay-
ments ranges from less than 0.1% to about 4%. The high-
est percentage of households incurring impoverishing 
effects is also close to 4%. The payment burden occurs 
in both insurance-based and tax-based health systems 
but more often in less wealthy countries. For example, 
the financial burden of OPPs is found to be highest in 
Latvia where the evidence indicates that in 2005, 33200 
households were prevented from seeking care or experi-
enced catastrophic payments. Currently many EU coun-
tries consider introducing or increasing OPP as a source 
of health care financing. These policy interventions shift 
healthcare costs to the patients and may further intensify 
the levels of the impoverishing and catastrophic effects of 
OPPs reported in the publications.
Nevertheless, the incidences of catastrophic and 
impoverishing effects of OPPs in the EU and accession 
countries are generally lower compared to developing 
countries in which no prepayment healthcare mecha-
nisms exist. Thus, although in some EU and accession 
countries, OPPs impose a greater burden on household 
finances than in others, all these countries are fairly suc-
cessful in ensuring access to health care and avoiding ma-
jor catastrophic or impoverishing effects of OPPs. Still, 
this positive view should not be a reason for policy-mak-
ers in Europe to neglect the problem. Even though the 
level of impoverishing and catastrophic effects of OPPs 
is relatively low at present, if these effects continue to 
persist they may further deepen the level of impover-
ishment. Moreover, OPPs measured in surveys do not 
always capture the informal patient payments. This sug-
gests that the financial burden of OPPs is probably higher 
than that measured in the studies.
The focus of most studies that we reviewed is limited 
to the analyses of the magnitude of the financial burden 
caused by OPPs. Coping mechanisms, such as borrow-
ing money to cover healthcare expenses, are not always 
analyzed. It is also not clear whether the catastrophic or 
impoverishing effects are incurred in only one year or 
whether these are repeated year after year for a house-
Poland [6] 2000
2003
2005
2007
2009
Social Diagno-
sis questionnai-
re-based study
3005
12381
not available 10% 9.3
11.6
9.7
11.8
13.5
Portugal [21, 23] 1994/1995 Income and 
Expenditure 
Survey
10450 not available 40% 2.7
Portugal [21, 23] 1990 Income and 
Expenditure 
Survey
12403 not available 40% 2.5
Romania [21, 23] 1994 Integrated 
Household 
Survey
2219 not available 40% 0.1
Slovakia [21, 23] 1993 Family expen-
diture Survey
2129 not available 40% 0.0*
Slovenia [21, 23] 1997/1998 Household 
Budget Survey
2577 not available 40% 0.1
Spain [21, 23] 1996 Encuesta 
Continua de 
Horgares
3104 not available 40% 0.5
Sweden [21, 23] 1996 Household 
Expenditure 
Survey
1103 not available 40% 0.2
Turkey [11] 2003
2006
2009
Houshold 
Budget 
Surveys
25920
8640
12600
21.65
23.41
23.79
40% 0.8
0.6
0.5
United 
Kingdom
[21, 23] 1999/2000 Family Expen-
diture Survey
7074 not available 40% 0.0*
*A bit less than 0.05%.
Table I. Catastrophic OPPs expenditure in the EU and accession countries.
244 Zeszyty Naukowe Ochrony Zdrowia
prywatne finansowanie ochrony zdrowia
hold. The duration over which catastrophic or impover-
ishing effects are felt by a household may be more im-
portant than the incidence of the effects in the population.
Some studies provide benchmarks to compare the 
magnitude and impact of OPPs on income/consumption 
quintiles. In lower income countries, particularly the 
population with the lowest-income is most at risk to incur 
high OPPs payments. Financial protection increases from 
the highest to the poorest population quintile in Latvia 
and Estonia, generally speaking for lower levels of fi-
nancial protection towards low income households. How-
ever, for France and Turkey, the evidence indicates that 
the better-off individuals tend to exceed the threshold as 
well. This can partly be explained because in wealthier 
countries, rich households tend to consume more health-
care services and goods. 
We also find in the review that in the EU and ac-
cession countries, well established financial protection 
mechanisms seem to exist for two healthcare compo-
nents: inpatient and outpatient care. This is probably be-
cause patients in the EU can more easily access publicly 
funded inpatient and outpatient services at low cost. The 
largest parts of OPPs for patients, however, are pharma-
ceutical expenditures such as medications. Especially 
for pharmaceutical expenditure, the data reviewed dem-
onstrate that direct and indirect OPPs are substantial in 
some EU countries, like Poland, and that catastrophic 
payments related to pharmaceuticals occur in every pop-
ulation quintile.
By looking at studies that analyze factors that in-
crease the likelihood for poorly protected households, it 
is difficult to compare the outcomes, as the studies do 
not use an identical set of factors. Still, the studies sug-
gest that households mostly impacted by high OPPs are 
single-pensioner households or households with at least 
one pensioner and female-headed households.
It should be noted however, that our review in-
cludes health systems that are very diverse and have 
very different systems of OPPs. In addition, there are 
different health indicators used in household budget 
surveys. Countries with low OPPs might need another 
measurement tool than the ones currently used to iden-
tify poverty gaps. The results also show that thresholds 
for measuring catastrophic and impoverishing effects 
of OPPs vary greatly between the studies. Comparable 
studies in the EU on catastrophic and impoverishing ef-
fects of OPPs have argued that in the EU, the threshold 
for measuring household financial burden should be set 
lower than 40% because EU countries have highly de-
veloped healthcare systems. Our review lists the overall 
thresholds that are used in the studies in the EU and ac-
cession countries concluding that a lower threshold to 
measure OPPs should be applied, as this better captures 
poverty effects in high income countries. 
As indicated by some publications included in our 
review, OPPs may negatively impact healthcare-seeking 
behavior, leading to foregoing health services or hospi-
talizations. This effect may increase the longer the cata-
strophic or impoverishing effects remain. Several coping 
mechanisms are identified in the literature, for instance 
borrowing money, selling assets, reallocating household 
spending or diversifying activities to generate income. In 
order to alleviate the high burden of OPPs, policies on 
financial protection should be incorporated in the general 
health policies to support patients who cannot afford to 
pay for health care. Current tax based or social insurance 
systems in the EU are not fully protecting citizens from 
these excessive payments. In most countries in the EU, 
the demand for healthcare is in line with needs. How-
ever, improving financial support for healthcare is likely 
to contribute to improving population health.
Our systematic literature review has several limita-
tions and should be viewed as a base line effort to present 
a systematic compilation of relevant publications. We in-
clude only papers published in English and therefore, we 
might have missed relevant publications in national jour-
nals. Also. the review is carried out in April–June 2013, 
which means that we might have missed relevant recent 
publications (e.g. [25]). Another problem that occurs is 
related to the comparability of the household survey data 
used in the studies. Specifically, the recall period varies 
across the studies. Surveys that apply a long recall period 
might be subject to misreporting due to the respondents’ 
inability to recall the exact OPPs. Also, studies use very 
different constructs for measuring the financial burden of 
OPPs and very different study designs. This means that 
the results are strongly dependent on the survey instru-
ment. Standardization of the survey designs would facili-
tate cross-country comparisons but could also discourage 
improvements of the survey designs. 
Conclusion and recommendation
As suggested by our review, OPPs place a financial 
burden (poverty and catastrophic effects) on households 
throughout the EU and accession countries. Future cost 
shifting may further aggravate this social problem. The 
level of catastrophic payments and impoverishing effects 
varies considerably across the countries and is difficult to 
compare due to differences in the study designs. Never-
theless, some trends are observed. In particular, the high-
est costs are OPPs for pharmaceuticals. Factors usually 
associated with the financial burden of OPPs include: 
living in a poor household, household with at least one 
pensioner and female headed households. Overall, the 
results support health policy changes towards the al-
leviation of poverty caused by OPPs. This view is also 
supported by the Health Strategy 2020 of the WHO to 
eradicate poverty by 2020 [26, 27]. It remains unclear 
however what changes in the healthcare system would 
be most effective in reducing the burden of OPPs as the 
countries have very different healthcare systems and very 
different types of OPPs. 
Our review identified only few empirical studies. It 
appears that the burden of OPPs in the EU and accession 
countries is not well studied. More cross-country evalu-
ation studies are needed as well as in-depth qualitative 
analysis with different healthcare stakeholders. In par-
ticular, the investigation of the health sector components 
related to pharmaceuticals can further contribute to our 
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understanding of OPPs and their impact on healthcare ex-
penditures. Future studies could also focus on challeng-
ing questions such as: How persistent are these poverty 
effects for individual households? What are the effects of 
specific healthcare reforms on poverty? Can these effects 
be foreseen before the reforms are implemented and can 
they be diminished by amending the reforms implemen-
tation? Are the current methods applied to study poverty 
and catastrophic effects of OOPs, powerful enough to 
capture details relevant to policy? What thresholds and 
welfare indicators are useful for policy-making in the 
EU and associated countries? How to standardize the 
methodology across the region? Future studies should 
also consider a long-term perspective and focus on the 
duration of the poverty effects of OPPs rather than just 
the incidence. 
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